Maximum quantity allowed is 999
Please select the quantity
CAS RN: 90098-04-7 | Product Number: R0085
Rebamipide
Purity: >98.0%(HPLC)
Synonyms:
- 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days |
---|---|---|---|
1G |
NT$2,920
|
9 | 8 |
5G |
NT$7,480
|
16 | Contact Us |
25G |
NT$23,160
|
12 | ≥40 |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | R0085 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__9H__1__5ClN__2O__4 = 370.79 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 90098-04-7 |
Reaxys Registry Number | 5384689 |
PubChem Substance ID | 125307349 |
Merck Index (14) | 8124 |
MDL Number | MFCD11114396 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 95.0 % |
Properties (reference)
Melting Point | 290 °C(dec.) |
GHS
Related Laws:
RTECS# | VC2518500 |
Transport Information:
H.S.code* | 2933.49-000 |
Application
Rebamipide: A Quinolinone Analog for Gastric Mucosal Protection
Rebamipide (OPC-12759), a 2(1H)-quinolinone analog, is used as an anti-gastritis and anti-gastric ulcer agent. It has been reported to have various activities in the gastric mucosa, such as stimulation of prostaglandin and mucus glycoprotein synthesis, inhibition of reactive oxygen species, inflammatory cytokines and chemokines, and inhibition of neutrophils activation. Furthermore, inhibition of gastric tumor growth by rebamipide has also been reported. In addition, rebamipide is used as a therapeutic adjunct for the treatment of infections caused by Helicobacter pylori. For your reference, we also have a related synthetic intermediate [O0468] of rebamipide. (The product is for research purpose only.)
References
- Studies on 2 (1H)-Quinolinone Derivatives as Gastric Antiulcer Active Agents. 2-(4-Chlorobenzoylamino)-3-[2 (1H)-quinolinon-4-yl] propionic Acid and Related Compounds
- Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat
- Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study
- 15th Anniversary of Rebamipide: Looking Ahead to the New Mechanisms and New Applications (a review)
- Rebamipide: a gastrointestinal protective drug with pleiotropic activities (a review)
- Optimization of forced degradation using experimental design and development of a stability-indicating liquid chromatographic assay method for rebamipide in bulk and tablet dosage form
Application
Induction of Cyclooxygenase-2 (COX-2) in Rat Gastric Mucosa by Rebamipide
Reference
- Induction of Cyclooxygenase-2 in Rat Gastric Mucosa by Rebamipide, a Mucoprotective Agent
- M. Yasumaru, H. Iijima, Y. Okuda, Y. Sasaki, M. Hori, S. Kawano, J. Pharmacol. Exp. Ther. 2000, 295, 447.
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.